Research progress of carboxyl peptide fragment of clostridium perfringens enterotoxin in the treatment of tumors / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 353-356, 2016.
Article
Dans Chinois
| WPRIM
| ID: wpr-493128
ABSTRACT
There are approximately 85 % of malignant tumors derived from epithelial cells,and a therapeutic method of epithelial cells has become the focus of cancer treatment.Claudin-3 and Claudin-4 as important components of the tight junction structure are abundantly expressed in malignant tumors,and the clostridium perfringens enterotoxin (CPE) as Claudin-3 and Claudin-4 specific binding ligand has important significances in the treatment of tumors.However,because of the large intestinal toxicity,clinical application of CPE has been limited greatly.Carboxyl peptide fragment of CPE (C-CPE) is a specific binding domain of CPE,which has specificity without intestinal toxicity.This review will present some advances of C-CPE in cancer therapy.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Cancer Research and Clinic
Année:
2016
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS